Clinical Trials Browser

Phase 2 × Liver Neoplasms × Docosahexaenoic Acids × Clear all

NCT00422877 2025-10-16

Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract

Phase 2 Terminated

Gastrointestinal

Liver Neoplasms